Intraoperative IV Iron on the Postoperative Recovery of Red Blood Cell in Hip Arthroplasty Surgery
Overview
- Phase
- Phase 4
- Intervention
- Ferric carboxymaltose
- Conditions
- Osteoarthritis, Hip
- Sponsor
- Konkuk University Medical Center
- Enrollment
- 46
- Primary Endpoint
- postoperative hematocrit (%)
- Last Updated
- 5 years ago
Overview
Brief Summary
The objective of the present study is to determine the impact of intraoperative IV-iron supplementation on postoperative recovery of RBC mass by retrospectively analyzing and comparing the changes of postoperative hematocrit values after the surgery in patients underwent elective uni-limb total knee arthroplasty surgery with or without IV-iron supplementation during surgery
Investigators
Tae-Yop Kim, MD PhD
Professor Anesthesiology
Konkuk University Medical Center
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
ferric carboxymaltose 1000 mg
Ferric carboxymaltose is administered during surgery
Intervention: Ferric carboxymaltose
control
Ferric carboxymaltose is not administered
Intervention: control
Outcomes
Primary Outcomes
postoperative hematocrit (%)
Time Frame: 7 days after surgery
hematocrit is evaluated on postoperative 7 days
Secondary Outcomes
- volume of post-operative bleeding (ml)(7 day)
- intraoperative blood transfusion (ml)(1 day)
- post-operative blood transfusion (ml)(7 days)
- post-operative serum ferritin level (ng/ml)(1 day)